Global NGS Tumor Gene Analysis Software Supply, Demand and Key Producers, 2023-2029
The global NGS Tumor Gene Analysis Software market size is expected to reach $ 4590 million by 2029, rising at a market growth of 16.7% CAGR during the forecast period (2023-2029).
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
This report studies the global NGS Tumor Gene Analysis Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for NGS Tumor Gene Analysis Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of NGS Tumor Gene Analysis Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global NGS Tumor Gene Analysis Software total market, 2018-2029, (USD Million)
Global NGS Tumor Gene Analysis Software total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: NGS Tumor Gene Analysis Software total market, key domestic companies and share, (USD Million)
Global NGS Tumor Gene Analysis Software revenue by player and market share 2018-2023, (USD Million)
Global NGS Tumor Gene Analysis Software total market by Type, CAGR, 2018-2029, (USD Million)
Global NGS Tumor Gene Analysis Software total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global NGS Tumor Gene Analysis Software market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World NGS Tumor Gene Analysis Software market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global NGS Tumor Gene Analysis Software Market, By Region:
1. How big is the global NGS Tumor Gene Analysis Software market?
2. What is the demand of the global NGS Tumor Gene Analysis Software market?
3. What is the year over year growth of the global NGS Tumor Gene Analysis Software market?
4. What is the total value of the global NGS Tumor Gene Analysis Software market?
5. Who are the major players in the global NGS Tumor Gene Analysis Software market?
6. What are the growth factors driving the market demand?
NGS (Next-Generation Sequencing) tumor gene analysis software refers to computer programs and tools designed to analyze genomic data obtained from the sequencing of tumor samples using next-generation sequencing technologies. These software applications are specifically developed to process and interpret the vast amount of genetic information generated by NGS platforms, allowing researchers and clinicians to identify genetic variants, mutations, and other genomic alterations associated with tumors.
This report studies the global NGS Tumor Gene Analysis Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for NGS Tumor Gene Analysis Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of NGS Tumor Gene Analysis Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global NGS Tumor Gene Analysis Software total market, 2018-2029, (USD Million)
Global NGS Tumor Gene Analysis Software total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: NGS Tumor Gene Analysis Software total market, key domestic companies and share, (USD Million)
Global NGS Tumor Gene Analysis Software revenue by player and market share 2018-2023, (USD Million)
Global NGS Tumor Gene Analysis Software total market by Type, CAGR, 2018-2029, (USD Million)
Global NGS Tumor Gene Analysis Software total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global NGS Tumor Gene Analysis Software market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World NGS Tumor Gene Analysis Software market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global NGS Tumor Gene Analysis Software Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-Small Cell Lung Cancer
- Human 6 Gene Mutations
- Human 12 Gene Mutations
- Other
- Hospitals and Health Systems
- Research Institute
- Other
- Roche
- Illumina
- Thermo Fisher Scientific
- BGI Group
- Novogene
- Geneseeq
- AmoyDx
- Burning Rock Medicine
- GTH.O
- Golden Helix, Inc
- Diatech Pharmacogenetics
- ViennaLab Diagnostics GmbH
- 3D Medicines
1. How big is the global NGS Tumor Gene Analysis Software market?
2. What is the demand of the global NGS Tumor Gene Analysis Software market?
3. What is the year over year growth of the global NGS Tumor Gene Analysis Software market?
4. What is the total value of the global NGS Tumor Gene Analysis Software market?
5. Who are the major players in the global NGS Tumor Gene Analysis Software market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 NGS Tumor Gene Analysis Software Introduction
1.2 World NGS Tumor Gene Analysis Software Market Size & Forecast (2018 & 2022 & 2029)
1.3 World NGS Tumor Gene Analysis Software Total Market by Region (by Headquarter Location)
1.3.1 World NGS Tumor Gene Analysis Software Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.3 China NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.4 Europe NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.5 Japan NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.6 South Korea NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.7 ASEAN NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.8 India NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 NGS Tumor Gene Analysis Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 NGS Tumor Gene Analysis Software Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.2 World NGS Tumor Gene Analysis Software Consumption Value by Region
2.2.1 World NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023)
2.2.2 World NGS Tumor Gene Analysis Software Consumption Value Forecast by Region (2024-2029)
2.3 United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.4 China NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.5 Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.6 Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.7 South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.8 ASEAN NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.9 India NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
3 WORLD NGS TUMOR GENE ANALYSIS SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World NGS Tumor Gene Analysis Software Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NGS Tumor Gene Analysis Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NGS Tumor Gene Analysis Software in 2022
3.2.3 Global Concentration Ratios (CR8) for NGS Tumor Gene Analysis Software in 2022
3.3 NGS Tumor Gene Analysis Software Company Evaluation Quadrant
3.4 NGS Tumor Gene Analysis Software Market: Overall Company Footprint Analysis
3.4.1 NGS Tumor Gene Analysis Software Market: Region Footprint
3.4.2 NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
3.4.3 NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NGS Tumor Gene Analysis Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NGS Tumor Gene Analysis Software Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: NGS Tumor Gene Analysis Software Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: NGS Tumor Gene Analysis Software Consumption Value Comparison
4.2.1 United States VS China: NGS Tumor Gene Analysis Software Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: NGS Tumor Gene Analysis Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based NGS Tumor Gene Analysis Software Companies and Market Share, 2018-2023
4.3.1 United States Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
4.4 China Based Companies NGS Tumor Gene Analysis Software Revenue and Market Share, 2018-2023
4.4.1 China Based NGS Tumor Gene Analysis Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
4.5 Rest of World Based NGS Tumor Gene Analysis Software Companies and Market Share, 2018-2023
4.5.1 Rest of World Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World NGS Tumor Gene Analysis Software Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-Small Cell Lung Cancer
5.2.2 Human 6 Gene Mutations
5.2.3 Human 12 Gene Mutations
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World NGS Tumor Gene Analysis Software Market Size by Type (2018-2023)
5.3.2 World NGS Tumor Gene Analysis Software Market Size by Type (2024-2029)
5.3.3 World NGS Tumor Gene Analysis Software Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World NGS Tumor Gene Analysis Software Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Health Systems
6.2.2 Research Institute
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World NGS Tumor Gene Analysis Software Market Size by Application (2018-2023)
6.3.2 World NGS Tumor Gene Analysis Software Market Size by Application (2024-2029)
6.3.3 World NGS Tumor Gene Analysis Software Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche NGS Tumor Gene Analysis Software Product and Services
7.1.4 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Illumina
7.2.1 Illumina Details
7.2.2 Illumina Major Business
7.2.3 Illumina NGS Tumor Gene Analysis Software Product and Services
7.2.4 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Illumina Recent Developments/Updates
7.2.6 Illumina Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Services
7.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 BGI Group
7.4.1 BGI Group Details
7.4.2 BGI Group Major Business
7.4.3 BGI Group NGS Tumor Gene Analysis Software Product and Services
7.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BGI Group Recent Developments/Updates
7.4.6 BGI Group Competitive Strengths & Weaknesses
7.5 Novogene
7.5.1 Novogene Details
7.5.2 Novogene Major Business
7.5.3 Novogene NGS Tumor Gene Analysis Software Product and Services
7.5.4 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Novogene Recent Developments/Updates
7.5.6 Novogene Competitive Strengths & Weaknesses
7.6 Geneseeq
7.6.1 Geneseeq Details
7.6.2 Geneseeq Major Business
7.6.3 Geneseeq NGS Tumor Gene Analysis Software Product and Services
7.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Geneseeq Recent Developments/Updates
7.6.6 Geneseeq Competitive Strengths & Weaknesses
7.7 AmoyDx
7.7.1 AmoyDx Details
7.7.2 AmoyDx Major Business
7.7.3 AmoyDx NGS Tumor Gene Analysis Software Product and Services
7.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AmoyDx Recent Developments/Updates
7.7.6 AmoyDx Competitive Strengths & Weaknesses
7.8 Burning Rock Medicine
7.8.1 Burning Rock Medicine Details
7.8.2 Burning Rock Medicine Major Business
7.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Services
7.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Burning Rock Medicine Recent Developments/Updates
7.8.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.9 GTH.O
7.9.1 GTH.O Details
7.9.2 GTH.O Major Business
7.9.3 GTH.O NGS Tumor Gene Analysis Software Product and Services
7.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GTH.O Recent Developments/Updates
7.9.6 GTH.O Competitive Strengths & Weaknesses
7.10 Golden Helix, Inc
7.10.1 Golden Helix, Inc Details
7.10.2 Golden Helix, Inc Major Business
7.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Services
7.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Golden Helix, Inc Recent Developments/Updates
7.10.6 Golden Helix, Inc Competitive Strengths & Weaknesses
7.11 Diatech Pharmacogenetics
7.11.1 Diatech Pharmacogenetics Details
7.11.2 Diatech Pharmacogenetics Major Business
7.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Services
7.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Diatech Pharmacogenetics Recent Developments/Updates
7.11.6 Diatech Pharmacogenetics Competitive Strengths & Weaknesses
7.12 ViennaLab Diagnostics GmbH
7.12.1 ViennaLab Diagnostics GmbH Details
7.12.2 ViennaLab Diagnostics GmbH Major Business
7.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Services
7.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ViennaLab Diagnostics GmbH Recent Developments/Updates
7.12.6 ViennaLab Diagnostics GmbH Competitive Strengths & Weaknesses
7.13 3D Medicines
7.13.1 3D Medicines Details
7.13.2 3D Medicines Major Business
7.13.3 3D Medicines NGS Tumor Gene Analysis Software Product and Services
7.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 3D Medicines Recent Developments/Updates
7.13.6 3D Medicines Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 NGS Tumor Gene Analysis Software Industry Chain
8.2 NGS Tumor Gene Analysis Software Upstream Analysis
8.3 NGS Tumor Gene Analysis Software Midstream Analysis
8.4 NGS Tumor Gene Analysis Software Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 NGS Tumor Gene Analysis Software Introduction
1.2 World NGS Tumor Gene Analysis Software Market Size & Forecast (2018 & 2022 & 2029)
1.3 World NGS Tumor Gene Analysis Software Total Market by Region (by Headquarter Location)
1.3.1 World NGS Tumor Gene Analysis Software Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.3 China NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.4 Europe NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.5 Japan NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.6 South Korea NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.7 ASEAN NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.3.8 India NGS Tumor Gene Analysis Software Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 NGS Tumor Gene Analysis Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 NGS Tumor Gene Analysis Software Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.2 World NGS Tumor Gene Analysis Software Consumption Value by Region
2.2.1 World NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023)
2.2.2 World NGS Tumor Gene Analysis Software Consumption Value Forecast by Region (2024-2029)
2.3 United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.4 China NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.5 Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.6 Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.7 South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.8 ASEAN NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
2.9 India NGS Tumor Gene Analysis Software Consumption Value (2018-2029)
3 WORLD NGS TUMOR GENE ANALYSIS SOFTWARE COMPANIES COMPETITIVE ANALYSIS
3.1 World NGS Tumor Gene Analysis Software Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global NGS Tumor Gene Analysis Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for NGS Tumor Gene Analysis Software in 2022
3.2.3 Global Concentration Ratios (CR8) for NGS Tumor Gene Analysis Software in 2022
3.3 NGS Tumor Gene Analysis Software Company Evaluation Quadrant
3.4 NGS Tumor Gene Analysis Software Market: Overall Company Footprint Analysis
3.4.1 NGS Tumor Gene Analysis Software Market: Region Footprint
3.4.2 NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
3.4.3 NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: NGS Tumor Gene Analysis Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: NGS Tumor Gene Analysis Software Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: NGS Tumor Gene Analysis Software Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: NGS Tumor Gene Analysis Software Consumption Value Comparison
4.2.1 United States VS China: NGS Tumor Gene Analysis Software Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: NGS Tumor Gene Analysis Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based NGS Tumor Gene Analysis Software Companies and Market Share, 2018-2023
4.3.1 United States Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
4.4 China Based Companies NGS Tumor Gene Analysis Software Revenue and Market Share, 2018-2023
4.4.1 China Based NGS Tumor Gene Analysis Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
4.5 Rest of World Based NGS Tumor Gene Analysis Software Companies and Market Share, 2018-2023
4.5.1 Rest of World Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World NGS Tumor Gene Analysis Software Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-Small Cell Lung Cancer
5.2.2 Human 6 Gene Mutations
5.2.3 Human 12 Gene Mutations
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World NGS Tumor Gene Analysis Software Market Size by Type (2018-2023)
5.3.2 World NGS Tumor Gene Analysis Software Market Size by Type (2024-2029)
5.3.3 World NGS Tumor Gene Analysis Software Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World NGS Tumor Gene Analysis Software Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospitals and Health Systems
6.2.2 Research Institute
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World NGS Tumor Gene Analysis Software Market Size by Application (2018-2023)
6.3.2 World NGS Tumor Gene Analysis Software Market Size by Application (2024-2029)
6.3.3 World NGS Tumor Gene Analysis Software Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche NGS Tumor Gene Analysis Software Product and Services
7.1.4 Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Illumina
7.2.1 Illumina Details
7.2.2 Illumina Major Business
7.2.3 Illumina NGS Tumor Gene Analysis Software Product and Services
7.2.4 Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Illumina Recent Developments/Updates
7.2.6 Illumina Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Services
7.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 BGI Group
7.4.1 BGI Group Details
7.4.2 BGI Group Major Business
7.4.3 BGI Group NGS Tumor Gene Analysis Software Product and Services
7.4.4 BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 BGI Group Recent Developments/Updates
7.4.6 BGI Group Competitive Strengths & Weaknesses
7.5 Novogene
7.5.1 Novogene Details
7.5.2 Novogene Major Business
7.5.3 Novogene NGS Tumor Gene Analysis Software Product and Services
7.5.4 Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Novogene Recent Developments/Updates
7.5.6 Novogene Competitive Strengths & Weaknesses
7.6 Geneseeq
7.6.1 Geneseeq Details
7.6.2 Geneseeq Major Business
7.6.3 Geneseeq NGS Tumor Gene Analysis Software Product and Services
7.6.4 Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Geneseeq Recent Developments/Updates
7.6.6 Geneseeq Competitive Strengths & Weaknesses
7.7 AmoyDx
7.7.1 AmoyDx Details
7.7.2 AmoyDx Major Business
7.7.3 AmoyDx NGS Tumor Gene Analysis Software Product and Services
7.7.4 AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AmoyDx Recent Developments/Updates
7.7.6 AmoyDx Competitive Strengths & Weaknesses
7.8 Burning Rock Medicine
7.8.1 Burning Rock Medicine Details
7.8.2 Burning Rock Medicine Major Business
7.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Services
7.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Burning Rock Medicine Recent Developments/Updates
7.8.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.9 GTH.O
7.9.1 GTH.O Details
7.9.2 GTH.O Major Business
7.9.3 GTH.O NGS Tumor Gene Analysis Software Product and Services
7.9.4 GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 GTH.O Recent Developments/Updates
7.9.6 GTH.O Competitive Strengths & Weaknesses
7.10 Golden Helix, Inc
7.10.1 Golden Helix, Inc Details
7.10.2 Golden Helix, Inc Major Business
7.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Services
7.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Golden Helix, Inc Recent Developments/Updates
7.10.6 Golden Helix, Inc Competitive Strengths & Weaknesses
7.11 Diatech Pharmacogenetics
7.11.1 Diatech Pharmacogenetics Details
7.11.2 Diatech Pharmacogenetics Major Business
7.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Services
7.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Diatech Pharmacogenetics Recent Developments/Updates
7.11.6 Diatech Pharmacogenetics Competitive Strengths & Weaknesses
7.12 ViennaLab Diagnostics GmbH
7.12.1 ViennaLab Diagnostics GmbH Details
7.12.2 ViennaLab Diagnostics GmbH Major Business
7.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Services
7.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ViennaLab Diagnostics GmbH Recent Developments/Updates
7.12.6 ViennaLab Diagnostics GmbH Competitive Strengths & Weaknesses
7.13 3D Medicines
7.13.1 3D Medicines Details
7.13.2 3D Medicines Major Business
7.13.3 3D Medicines NGS Tumor Gene Analysis Software Product and Services
7.13.4 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 3D Medicines Recent Developments/Updates
7.13.6 3D Medicines Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 NGS Tumor Gene Analysis Software Industry Chain
8.2 NGS Tumor Gene Analysis Software Upstream Analysis
8.3 NGS Tumor Gene Analysis Software Midstream Analysis
8.4 NGS Tumor Gene Analysis Software Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World NGS Tumor Gene Analysis Software Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World NGS Tumor Gene Analysis Software Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World NGS Tumor Gene Analysis Software Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NGS Tumor Gene Analysis Software Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World NGS Tumor Gene Analysis Software Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World NGS Tumor Gene Analysis Software Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key NGS Tumor Gene Analysis Software Players in 2022
Table 12. World NGS Tumor Gene Analysis Software Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global NGS Tumor Gene Analysis Software Company Evaluation Quadrant
Table 14. Head Office of Key NGS Tumor Gene Analysis Software Player
Table 15. NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
Table 16. NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
Table 17. NGS Tumor Gene Analysis Software Mergers & Acquisitions Activity
Table 18. United States VS China NGS Tumor Gene Analysis Software Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China NGS Tumor Gene Analysis Software Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 23. China Based NGS Tumor Gene Analysis Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 26. Rest of World Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 29. World NGS Tumor Gene Analysis Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World NGS Tumor Gene Analysis Software Market Size by Type (2018-2023) & (USD Million)
Table 31. World NGS Tumor Gene Analysis Software Market Size by Type (2024-2029) & (USD Million)
Table 32. World NGS Tumor Gene Analysis Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World NGS Tumor Gene Analysis Software Market Size by Application (2018-2023) & (USD Million)
Table 34. World NGS Tumor Gene Analysis Software Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche NGS Tumor Gene Analysis Software Product and Services
Table 38. Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Area Served and Competitors
Table 42. Illumina Major Business
Table 43. Illumina NGS Tumor Gene Analysis Software Product and Services
Table 44. Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Services
Table 50. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. BGI Group Basic Information, Area Served and Competitors
Table 54. BGI Group Major Business
Table 55. BGI Group NGS Tumor Gene Analysis Software Product and Services
Table 56. BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BGI Group Recent Developments/Updates
Table 58. BGI Group Competitive Strengths & Weaknesses
Table 59. Novogene Basic Information, Area Served and Competitors
Table 60. Novogene Major Business
Table 61. Novogene NGS Tumor Gene Analysis Software Product and Services
Table 62. Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Novogene Recent Developments/Updates
Table 64. Novogene Competitive Strengths & Weaknesses
Table 65. Geneseeq Basic Information, Area Served and Competitors
Table 66. Geneseeq Major Business
Table 67. Geneseeq NGS Tumor Gene Analysis Software Product and Services
Table 68. Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Geneseeq Recent Developments/Updates
Table 70. Geneseeq Competitive Strengths & Weaknesses
Table 71. AmoyDx Basic Information, Area Served and Competitors
Table 72. AmoyDx Major Business
Table 73. AmoyDx NGS Tumor Gene Analysis Software Product and Services
Table 74. AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AmoyDx Recent Developments/Updates
Table 76. AmoyDx Competitive Strengths & Weaknesses
Table 77. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 78. Burning Rock Medicine Major Business
Table 79. Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Services
Table 80. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Burning Rock Medicine Recent Developments/Updates
Table 82. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 83. GTH.O Basic Information, Area Served and Competitors
Table 84. GTH.O Major Business
Table 85. GTH.O NGS Tumor Gene Analysis Software Product and Services
Table 86. GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GTH.O Recent Developments/Updates
Table 88. GTH.O Competitive Strengths & Weaknesses
Table 89. Golden Helix, Inc Basic Information, Area Served and Competitors
Table 90. Golden Helix, Inc Major Business
Table 91. Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Services
Table 92. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Golden Helix, Inc Recent Developments/Updates
Table 94. Golden Helix, Inc Competitive Strengths & Weaknesses
Table 95. Diatech Pharmacogenetics Basic Information, Area Served and Competitors
Table 96. Diatech Pharmacogenetics Major Business
Table 97. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Services
Table 98. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Diatech Pharmacogenetics Recent Developments/Updates
Table 100. Diatech Pharmacogenetics Competitive Strengths & Weaknesses
Table 101. ViennaLab Diagnostics GmbH Basic Information, Area Served and Competitors
Table 102. ViennaLab Diagnostics GmbH Major Business
Table 103. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Services
Table 104. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. ViennaLab Diagnostics GmbH Recent Developments/Updates
Table 106. 3D Medicines Basic Information, Area Served and Competitors
Table 107. 3D Medicines Major Business
Table 108. 3D Medicines NGS Tumor Gene Analysis Software Product and Services
Table 109. 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of NGS Tumor Gene Analysis Software Upstream (Raw Materials)
Table 111. NGS Tumor Gene Analysis Software Typical Customers
Table 1. World NGS Tumor Gene Analysis Software Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World NGS Tumor Gene Analysis Software Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World NGS Tumor Gene Analysis Software Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World NGS Tumor Gene Analysis Software Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World NGS Tumor Gene Analysis Software Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World NGS Tumor Gene Analysis Software Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World NGS Tumor Gene Analysis Software Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key NGS Tumor Gene Analysis Software Players in 2022
Table 12. World NGS Tumor Gene Analysis Software Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global NGS Tumor Gene Analysis Software Company Evaluation Quadrant
Table 14. Head Office of Key NGS Tumor Gene Analysis Software Player
Table 15. NGS Tumor Gene Analysis Software Market: Company Product Type Footprint
Table 16. NGS Tumor Gene Analysis Software Market: Company Product Application Footprint
Table 17. NGS Tumor Gene Analysis Software Mergers & Acquisitions Activity
Table 18. United States VS China NGS Tumor Gene Analysis Software Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China NGS Tumor Gene Analysis Software Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
Table 21. United States Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 23. China Based NGS Tumor Gene Analysis Software Companies, Headquarters (Province, Country)
Table 24. China Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 26. Rest of World Based NGS Tumor Gene Analysis Software Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies NGS Tumor Gene Analysis Software Revenue Market Share (2018-2023)
Table 29. World NGS Tumor Gene Analysis Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World NGS Tumor Gene Analysis Software Market Size by Type (2018-2023) & (USD Million)
Table 31. World NGS Tumor Gene Analysis Software Market Size by Type (2024-2029) & (USD Million)
Table 32. World NGS Tumor Gene Analysis Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World NGS Tumor Gene Analysis Software Market Size by Application (2018-2023) & (USD Million)
Table 34. World NGS Tumor Gene Analysis Software Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche NGS Tumor Gene Analysis Software Product and Services
Table 38. Roche NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Illumina Basic Information, Area Served and Competitors
Table 42. Illumina Major Business
Table 43. Illumina NGS Tumor Gene Analysis Software Product and Services
Table 44. Illumina NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Illumina Recent Developments/Updates
Table 46. Illumina Competitive Strengths & Weaknesses
Table 47. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 48. Thermo Fisher Scientific Major Business
Table 49. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product and Services
Table 50. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Thermo Fisher Scientific Recent Developments/Updates
Table 52. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 53. BGI Group Basic Information, Area Served and Competitors
Table 54. BGI Group Major Business
Table 55. BGI Group NGS Tumor Gene Analysis Software Product and Services
Table 56. BGI Group NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. BGI Group Recent Developments/Updates
Table 58. BGI Group Competitive Strengths & Weaknesses
Table 59. Novogene Basic Information, Area Served and Competitors
Table 60. Novogene Major Business
Table 61. Novogene NGS Tumor Gene Analysis Software Product and Services
Table 62. Novogene NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Novogene Recent Developments/Updates
Table 64. Novogene Competitive Strengths & Weaknesses
Table 65. Geneseeq Basic Information, Area Served and Competitors
Table 66. Geneseeq Major Business
Table 67. Geneseeq NGS Tumor Gene Analysis Software Product and Services
Table 68. Geneseeq NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Geneseeq Recent Developments/Updates
Table 70. Geneseeq Competitive Strengths & Weaknesses
Table 71. AmoyDx Basic Information, Area Served and Competitors
Table 72. AmoyDx Major Business
Table 73. AmoyDx NGS Tumor Gene Analysis Software Product and Services
Table 74. AmoyDx NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AmoyDx Recent Developments/Updates
Table 76. AmoyDx Competitive Strengths & Weaknesses
Table 77. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 78. Burning Rock Medicine Major Business
Table 79. Burning Rock Medicine NGS Tumor Gene Analysis Software Product and Services
Table 80. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Burning Rock Medicine Recent Developments/Updates
Table 82. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 83. GTH.O Basic Information, Area Served and Competitors
Table 84. GTH.O Major Business
Table 85. GTH.O NGS Tumor Gene Analysis Software Product and Services
Table 86. GTH.O NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. GTH.O Recent Developments/Updates
Table 88. GTH.O Competitive Strengths & Weaknesses
Table 89. Golden Helix, Inc Basic Information, Area Served and Competitors
Table 90. Golden Helix, Inc Major Business
Table 91. Golden Helix, Inc NGS Tumor Gene Analysis Software Product and Services
Table 92. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Golden Helix, Inc Recent Developments/Updates
Table 94. Golden Helix, Inc Competitive Strengths & Weaknesses
Table 95. Diatech Pharmacogenetics Basic Information, Area Served and Competitors
Table 96. Diatech Pharmacogenetics Major Business
Table 97. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product and Services
Table 98. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Diatech Pharmacogenetics Recent Developments/Updates
Table 100. Diatech Pharmacogenetics Competitive Strengths & Weaknesses
Table 101. ViennaLab Diagnostics GmbH Basic Information, Area Served and Competitors
Table 102. ViennaLab Diagnostics GmbH Major Business
Table 103. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product and Services
Table 104. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. ViennaLab Diagnostics GmbH Recent Developments/Updates
Table 106. 3D Medicines Basic Information, Area Served and Competitors
Table 107. 3D Medicines Major Business
Table 108. 3D Medicines NGS Tumor Gene Analysis Software Product and Services
Table 109. 3D Medicines NGS Tumor Gene Analysis Software Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 110. Global Key Players of NGS Tumor Gene Analysis Software Upstream (Raw Materials)
Table 111. NGS Tumor Gene Analysis Software Typical Customers
LIST OF FIGURES
Figure 1. NGS Tumor Gene Analysis Software Picture
Figure 2. World NGS Tumor Gene Analysis Software Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World NGS Tumor Gene Analysis Software Total Market Size (2018-2029) & (USD Million)
Figure 4. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 13. NGS Tumor Gene Analysis Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 16. World NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 17. United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 18. China NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 23. India NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of NGS Tumor Gene Analysis Software by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for NGS Tumor Gene Analysis Software Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for NGS Tumor Gene Analysis Software Markets in 2022
Figure 27. United States VS China: NGS Tumor Gene Analysis Software Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: NGS Tumor Gene Analysis Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World NGS Tumor Gene Analysis Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World NGS Tumor Gene Analysis Software Market Size Market Share by Type in 2022
Figure 31. Non-Small Cell Lung Cancer
Figure 32. Human 6 Gene Mutations
Figure 33. Human 12 Gene Mutations
Figure 34. Other
Figure 35. World NGS Tumor Gene Analysis Software Market Size Market Share by Type (2018-2029)
Figure 36. World NGS Tumor Gene Analysis Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World NGS Tumor Gene Analysis Software Market Size Market Share by Application in 2022
Figure 38. Hospitals and Health Systems
Figure 39. Research Institute
Figure 40. Other
Figure 41. NGS Tumor Gene Analysis Software Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. NGS Tumor Gene Analysis Software Picture
Figure 2. World NGS Tumor Gene Analysis Software Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World NGS Tumor Gene Analysis Software Total Market Size (2018-2029) & (USD Million)
Figure 4. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World NGS Tumor Gene Analysis Software Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company NGS Tumor Gene Analysis Software Revenue (2018-2029) & (USD Million)
Figure 13. NGS Tumor Gene Analysis Software Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 16. World NGS Tumor Gene Analysis Software Consumption Value Market Share by Region (2018-2029)
Figure 17. United States NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 18. China NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 23. India NGS Tumor Gene Analysis Software Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of NGS Tumor Gene Analysis Software by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for NGS Tumor Gene Analysis Software Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for NGS Tumor Gene Analysis Software Markets in 2022
Figure 27. United States VS China: NGS Tumor Gene Analysis Software Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: NGS Tumor Gene Analysis Software Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World NGS Tumor Gene Analysis Software Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World NGS Tumor Gene Analysis Software Market Size Market Share by Type in 2022
Figure 31. Non-Small Cell Lung Cancer
Figure 32. Human 6 Gene Mutations
Figure 33. Human 12 Gene Mutations
Figure 34. Other
Figure 35. World NGS Tumor Gene Analysis Software Market Size Market Share by Type (2018-2029)
Figure 36. World NGS Tumor Gene Analysis Software Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World NGS Tumor Gene Analysis Software Market Size Market Share by Application in 2022
Figure 38. Hospitals and Health Systems
Figure 39. Research Institute
Figure 40. Other
Figure 41. NGS Tumor Gene Analysis Software Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
